Mathematical modeling of cancer progression and response to chemotherapy

The complex, constantly evolving and multifaceted nature of cancer has made it difficult to identify unique molecular and pathophysiological signatures for each disease variant, consequently hindering development of effective therapies. Mathematical modeling and computer simulation are tools that can provide a robust framework to better understand cancer progression and response to chemotherapy. Successful therapeutic agents must overcome biological barriers occurring at multiple space and time scales and still reach targets at sufficient concentrations. A multiscale computer simulator founded on the integration of experimental data and mathematical models can provide valuable insights into these processes and establish a technology platform for analyzing the effectiveness of chemotherapeutic drugs, with the potential to cost-effectively and efficiently screen drug candidates during the drug-development process.

[1]  A Fahr,et al.  Compartment modeling. , 2001, Advanced drug delivery reviews.

[2]  Simulation model of doxorubicin activity in islets of human breast cancer cells. , 2003, Biochimica et biophysica acta.

[3]  A. Telser.  Molecular Biology of the Cell, 4th Edition , 2002 .

[4]  H M Byrne,et al.  Growth of nonnecrotic tumors in the presence and absence of inhibitors. , 1995, Mathematical biosciences.

[5]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[6]  H. Frieboes,et al.  Mathematical and Computational Modeling: Towards the Development and Application of Nanodevices for Drug Delivery , 2007 .

[7]  A C Burton,et al.  Rate of growth of solid tumours as a problem of diffusion. , 1966, Growth.

[8]  M. Markus,et al.  Simulation of vessel morphogenesis using cellular automata. , 1999, Mathematical biosciences.

[9]  C. Graham,et al.  Oxygen-mediated Regulation of Tumor Cell Invasiveness , 2002, The Journal of Biological Chemistry.

[10]  V. Cristini,et al.  Nonlinear simulation of tumor growth , 2003, Journal of mathematical biology.

[11]  Sudhir Gupta,et al.  Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review). , 2003, International journal of oncology.

[12]  Mauro Ferrari,et al.  Morphologic Instability and Cancer Invasion , 2005, Clinical Cancer Research.

[13]  Shea N Gardner,et al.  Modeling multi-drug chemotherapy: tailoring treatment to individuals. , 2002, Journal of theoretical biology.

[14]  D. L. Sean McElwain,et al.  A Mixture Theory for the Genesis of Residual Stresses in Growing Tissues I: A General Formulation , 2005, SIAM J. Appl. Math..

[15]  R. W. Hansen,et al.  The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.

[16]  T. Secomb,et al.  Two-mechanism peak concentration model for cellular pharmacodynamics of Doxorubicin. , 2005, Neoplasia.

[17]  Nicolas P. Smith,et al.  Mathematical modelling of the heart: cell to organ , 2002 .

[18]  Burton Ac,et al.  Rate of growth of solid tumours as a problem of diffusion. , 1966, Growth.

[19]  S A Newman,et al.  On multiscale approaches to three-dimensional modelling of morphogenesis , 2005, Journal of The Royal Society Interface.

[20]  Rakesh K. Jain,et al.  Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy , 2001, Nature Medicine.

[21]  Roeland M. H. Merks,et al.  Dynamic mechanisms of blood vessel growth , 2006, Nonlinearity.

[22]  J C Panetta,et al.  A mathematical model of breast and ovarian cancer treated with paclitaxel. , 1997, Mathematical biosciences.

[23]  D L S McElwain,et al.  A history of the study of solid tumour growth: The contribution of mathematical modelling , 2004, Bulletin of mathematical biology.

[24]  P. Workman.  How much gets there and what does it do?: The need for better pharmacokinetic and pharmacodynamic endpoints in contemporary drug discovery and development. , 2003, Current pharmaceutical design.

[25]  Sophia Maggelakis,et al.  Mathematical model of prevascular growth of a spherical carcinoma-part II , 1993 .

[26]  L. H. Gray,et al.  The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy , 1955, British Journal of Cancer.

[27]  J. King,et al.  Mathematical modelling of avascular-tumour growth. , 1997, IMA journal of mathematics applied in medicine and biology.

[28]  J. Lowengrub,et al.  Nonlinear simulation of the effect of microenvironment on tumor growth. , 2007, Journal of theoretical biology.

[29]  J. King,et al.  Mathematical modelling of avascular-tumour growth. II: Modelling growth saturation. , 1999, IMA journal of mathematics applied in medicine and biology.

[30]  Alexander R. A. Anderson,et al.  Mathematical modelling of flow in 2D and 3D vascular networks: Applications to anti-angiogenic and chemotherapeutic drug strategies , 2005, Math. Comput. Model..

[31]  S. Howell,et al.  Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane by digitonin in vitro. , 1993, Biochemical pharmacology.

[32]  Graeme J. Pettet,et al.  AVASCULAR TUMOUR DYNAMICS AND NECROSIS , 1999 .

[33]  Timothy W Secomb,et al.  A mathematical model for cisplatin cellular pharmacodynamics. , 2003, Neoplasia.

[34]  P. Maini,et al.  A cellular automaton model for tumour growth in inhomogeneous environment. , 2003, Journal of theoretical biology.

[35]  F. Migliavacca,et al.  Multiscale modeling of the cardiovascular system: application to the study of pulmonary and coronary perfusions in the univentricular circulation. , 2005, Journal of biomechanics.

[36]  S. Schnell,et al.  A multiscale mathematical model of cancer, and its use in analyzing irradiation therapies , 2006, Theoretical Biology and Medical Modelling.

[37]  J. Fruehauf,et al.  In vitro assay-assisted treatment selection for women with breast or ovarian cancer. , 2002, Endocrine-related cancer.

[38]  S. McDougall,et al.  Mathematical modelling of flow through vascular networks: Implications for tumour-induced angiogenesis and chemotherapy strategies , 2002, Bulletin of mathematical biology.

[39]  B. Teicher.  Hypoxia and drug resistance , 1994, Cancer and Metastasis Reviews.

[40]  P. Hunter,et al.  Computational physiology and the physiome project , 2004, Experimental physiology.

[41]  Helen M. Byrne,et al.  A Multiple Scale Model for Tumor Growth , 2005, Multiscale Model. Simul..

[42]  David H. Sharp,et al.  Multiscale modeling of developmental processes , 1993 .

[43]  M. Westphal,et al.  Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. , 2001, Cancer research.

[44]  H. Frieboes,et al.  An integrated computational/experimental model of tumor invasion. , 2006, Cancer research.

[45]  Graeme J. Pettet,et al.  A new approach to modelling the formation of necrotic regions in tumours , 1998 .

[46]  G Milano,et al.  Effects of prolonged exposure to cisplatin on cytotoxicity and intracellular drug concentration. , 1992, European journal of cancer.

[47]  Trachette L. Jackson,et al.  Intracellular accumulation and mechanism of action of doxorubicin in a spatio-temporal tumor model. , 2003, Journal of theoretical biology.

[48]  V. Cristini,et al.  Three-Dimensional Diffuse-Interface Simulation of Multispecies Tumor Growth – II : Investigation of Tumor Invasion , 2006 .

[49]  Z. Agur,et al.  A computer algorithm describing the process of vessel formation and maturation, and its use for predicting the effects of anti-angiogenic and anti-maturation therapy on vascular tumor growth , 2004, Angiogenesis.

[50]  Helen M Byrne,et al.  A multiphase model describing vascular tumour growth , 2003, Bulletin of mathematical biology.

[51]  Orhan Nalcioglu,et al.  Nanotechnology in Cancer Drug Therapy: A Biocomputational Approach , 2006 .

[52]  B. Reglin,et al.  Structural Adaptation of Vascular Networks: Role of the Pressure Response , 2001, Hypertension.

[53]  J. Winter,et al.  Flow cytometric assessment of the cellular pharmacokinetics of fluorescent drugs. , 1995, Cytometry.

[54]  Roeland M. H. Merks,et al.  A cell-centered approach to developmental biology , 2005 .

[55]  M. Ferrari.  Nanovector therapeutics. , 2005, Current opinion in chemical biology.

[56]  B. Alberts,et al.  Molecular Biology of the Cell 4th edition , 2007 .

[57]  Vittorio Cristini,et al.  An adaptive mesh algorithm for evolving surfaces: simulation of drop breakup and coalescence , 2001 .

[58]  Denis Noble,et al.  Integrative models of the heart: achievements and limitations , 2001, Philosophical Transactions of the Royal Society of London. Series A: Mathematical, Physical and Engineering Sciences.

[59]  J Folkman,et al.  Transplacental carcinogenesis by stilbestrol. , 1971, The New England journal of medicine.

[60]  Larry L. Augsburger,et al.  Selected physical and chemical properties of commercial Hypericum perforatum extracts relevant for formulated product quality and performance , 2001, AAPS PharmSci.

[61]  R. Hill,et al.  Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. , 2001, Cancer research.

[62]  H M Byrne,et al.  Growth of necrotic tumors in the presence and absence of inhibitors. , 1996, Mathematical biosciences.

[63]  M. Chaplain,et al.  Continuous and discrete mathematical models of tumor-induced angiogenesis , 1998, Bulletin of mathematical biology.

[64]  H. Greenspan.  Models for the Growth of a Solid Tumor by Diffusion , 1972 .

[65]  V. Cristini,et al.  Nonlinear simulation of tumor necrosis, neo-vascularization and tissue invasion via an adaptive finite-element/level-set method , 2005, Bulletin of mathematical biology.

[66]  Andreas Deutsch,et al.  Cellular Automaton Models of Tumor Development: a Critical Review , 2002, Adv. Complex Syst..

[67]  E. Rofstad,et al.  Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor. , 2002, Cancer research.

[68]  G. S. H. Lock,et al.  The effects of tilt, skew and roll on natural convection in a slender, laterally-heated cavity , 1990 .

[69]  R K Jain,et al.  Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[70]  A. Pries,et al.  Control of blood vessel structure: insights from theoretical models. , 2005, American journal of physiology. Heart and circulatory physiology.

[71]  Robert A. Gatenby,et al.  Mathematical models of tumor-host interactions , 1998 .

[72]  L. Mayer,et al.  Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[73]  Jelena Pjesivac-Grbovic,et al.  A multiscale model for avascular tumor growth. , 2005, Biophysical journal.

[74]  H. Byrne,et al.  The role of cell-cell interactions in a two-phase model for avascular tumour growth , 2002, Journal of mathematical biology.

[75]  J. Folkman,et al.  Angiogenic factors. , 1987, Science.

[76]  P. Maini,et al.  Mathematical oncology: Cancer summed up , 2003, Nature.

[77]  H. Frieboes,et al.  Two-dimensional chemotherapy simulations demonstrate fundamental transport and tumor response limitations involving nanoparticles. , 2005, Biomedical microdevices.

[78]  Xiaoming Zheng,et al.  Adaptive unstructured volume remeshing - I: The method , 2005 .

[79]  P. Comoglio,et al.  Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. , 2003, Cancer cell.

[80]  Alexander R. A. Anderson,et al.  Mathematical modelling of the influence of blood rheological properties upon adaptative tumour-induced angiogenesis , 2006, Math. Comput. Model..

[81]  H. Othmer,et al.  Mathematical modeling of tumor-induced angiogenesis , 2004, Journal of mathematical biology.

[82]  C. Chen,et al.  Time-and concentration-dependent penetration of doxorubicin in prostate tumors , 2001, AAPS PharmSci.

[83]  R. Knuechel,et al.  Multicellular spheroids: a three‐dimensional in vitro culture system to study tumour biology , 1998, International journal of experimental pathology.

[84]  S. McDougall,et al.  Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies. , 2006, Journal of theoretical biology.